Drug Trial Radar · NCT03768427
Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)
Last checked: Nov 19, 2026Latest source record: May 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
454
Actual
Start
May 27, 2019
Primary completion
Mar 17, 2021
Study completion Apr 1, 2021
Sponsor
- Lead sponsor
- Organon and CoIndustry
- Sponsor type
- Industry
- First posted
- Dec 7, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the EZ/Ator fixed-dose combination (FDC) tablet (MK-0653C) as second line Low-Density Lipoprotein - Cholesterol (LDL-C) treatment in Chinese participants. The primary hypothesis is that MK-0653C 10/10 mg is superior to atorvastatin 20 mg in percent change from baseline in LDL-C to 12 weeks after treatment.
Conditions
- Hypercholesterolemia
Interventions
EZ 10 mg/Ator 10 mgCombination product
FDC of EZ10 mg/Ator 10mg
EZ 10 mg/Ator 20 mgCombination product
FDC of EZ10 mg/Ator 20mg
AtorvastatinDrug
Atorvastatin administered orally QD, either as two 10 mg tablets or as two 20 mg tablets
Placebo for FDC EZ/AtorDrug
A single placebo tablet administered orally QD for 84 days
Placebo for atorvastatinDrug
Two placebo tablets matching atorvastatin administered orally QD for 84 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in LDL-C at Week 12Time frame: Baseline (Day 1) and Week 12
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Baotou Medical College ( Site 0025)
Baotou, Anhui, China
Beijing Anzhen Hospital. Capital Medical University ( Site 0001)
Beijing, Anhui, China
Aero Space center hospital ( Site 0003)
Beijing, Beijing Municipality, China
Beijing Friendship Hospital ( Site 0005)
Beijing, Beijing Municipality, China
Chongqing General Hospital ( Site 0037)
Chongqing, Chongqing Municipality, China
Lanzhou University Second Hospital ( Site 0041)
Lanzhou, Gansu, China
Guangdong General Hospital ( Site 0006)
Guangzhou, Guangdong, China
The First Affiliated Hospital.Sun Yat-sen University ( Site 0007)
Guangzhou, Guangdong, China
Sun Yat-sen Memorial Hospital of Sun Yat-sen University ( Site 0008)
Guangzhou, Guangdong, China
Daqing Oilfield General Hospital ( Site 0010)
Daqing, Heilongjiang, China
The first affiliated Hospital of Harbin Medical University ( Site 0009)
Haerbin, Heilongjiang, China
The Third Xiangya Hospital of Central South University ( Site 0013)
Changsha, Hunan, China
Hunan Provincial People's Hospital ( Site 0011)
Changsha, Hunan, China
Zhongda Hospital Southeast University ( Site 0045)
Nanjing, Jiangsu, China
The Second Affiliated Hospital of Nanjing Medical University ( Site 0020)
Nanjing, Jiangsu, China
First Affiliated Hospital of Soochow University ( Site 0048)
Suzhou, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University ( Site 0017)
Xuzhou, Jiangsu, China
Subei People's Hospital ( Site 0040)
Yangzhou, Jiangsu, China
Second Affiliated Hospital of Nanchang University ( Site 0038)
Nanchang, Jiangxi, China
Ji Lin Province People Hospital ( Site 0016)
Changchun, Jilin, China
China-Japan Union Hospital of Jilin University ( Site 0015)
Changchun, Jilin, China
Central People s Hospital of Siping ( Site 0046)
Siping, Jilin, China
The People's Hospital of Liaoning Province-Cardiovascular ( Site 0022)
Shenyang, Liaoning, China
Zhongshan Hospital Fudan University ( Site 0049)
Shanghai, Shanghai Municipality, China
Shanghai Tongji Hospital ( Site 0031)
Shanghai, Shanghai Municipality, China
Tianjin Union Medicine Centre ( Site 0032)
Tianjin, Tianjin Municipality, China
People s Hospital of Lishui City ( Site 0036)
Lishui, Zhejiang, China
Ningbo First Hospital ( Site 0042)
Ningbo, Zhejiang, China
Taizhou Hospital of Zhejiang Province ( Site 0035)
Taizhou, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University ( Site 0034)
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.